Corcept Therapeutics Incorporated Insider Sells $13,005.00 in Stock.

Insider Joseph Douglas Lyon sold 500 shares of Corcept Therapeutics, a NASDAQ-listed biotech firm, for an average price of $26.01 each, resulting in a total value of $13,005. The company, which develops drugs for severe endocrinologic, oncologic, metabolic, and neurologic disorders, reported earnings of $0.28 per share for the quarter ended February 15th, surpassing consensus estimates. Corcept Therapeutics has a market cap of $2.61 billion, a price-to-earnings ratio (P/E) of 26.53, and a beta of 0.48.

April 06, 2024
5 Articles